Epigenetics of chronic rhinosinusitis and the role of the eosinophil

International Forum of Allergy and Rhinology

Volumn 2, Issue 1, 2012, Pages 80-84

  Seiberling, Kristin A ^a   Church, Christopher A ^a   Herring, Jason L ^a   Sowers, Lawrence C ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

Bromocytosine; Chronic rhinosinusitis; Eosinophil; Epigenetics; Gene alteration; Innate immune system; Nasal polyps

Indexed keywords

5 BROMOCYTOSINE; 5 CHLOROCYTOSINE; CYTOSINE; HYPOBROMOUS ACID; HYPOCHLOROUS ACID; INORGANIC ACID; UNCLASSIFIED DRUG; 5-BROMOCYTOSINE; 5-CHLOROCYTOSINE; BROMATE; DRUG DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; DNA REPLICATION; EOSINOPHIL; EPIGENETICS; FEMALE; GAS CHROMATOGRAPHY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; METHYLATION; MUTATION; NEUTROPHIL; NOSE POLYP; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; CASE CONTROL STUDY; CHRONIC DISEASE; GENETICS; MASS FRAGMENTOGRAPHY; METABOLISM; MIDDLE AGED; NOSE MUCOSA; RHINITIS; SINUSITIS;

ADULT; AGED; AGED, 80 AND OVER; BROMATES; CASE-CONTROL STUDIES; CHRONIC DISEASE; CYTOSINE; EOSINOPHILS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYPOCHLOROUS ACID; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; RHINITIS; SINUSITIS; YOUNG ADULT;

EID: 84861118992     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.20090     Document Type: Article

References (30)

1. Fokkens W, Lund V, Mullol J. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology. 2007;45:97-101.
2. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001;107:607-614.
3. Mygind N, Dahl R, Bachert C. Nasal polyposis, eosinophil dominated inflammation, and allergy. Thorax. 2000;55(Suppl 2):S79-S83.
4. Hamilos DL, Leung DY, Wood R, et al. Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol. 1993;92:39-48.
5. Ponikau JU, Sherris DA, Kephart GM, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma? J Allergy Clin Immunol. 2003;112:877-882.
6. Gleich GJ, Adolphson CR, Leiferman KM. The biology of the eosinophilic leukocyte. Annu Rev Med. 1993;44:85-101.
7. Frigas E, Loegering DA, Gleich GJ. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest. 1980;42:35-43.
8. Hisamatsu K, Ganbo T, Nakazawa T et al. Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitro. J Allergy Clin Immunol 1990;86:52-63.
9. Gleich GJ, Flavahan NA, Fujisawa T, Vanhoutte PM. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol 1988;81:776-781.
10. Weiss SJ, Test ST, Eckmann CM, Roos D. Regiani S. Brominating oxidants generated by human eosinophils. Science. 1986;234:200-203.
11. Byun J, Henderson JP, Heinecke JW. Identification and quantification of mutagenic halogenated cytosines by gas chromatography, fast atom bombardment, and electrospray ionization tandem mass spectrometry. Analytical Biochemistry 2003;317:201-209.
12. Wu W, Chen Y, D'Avignon A, Hazen SL. 3-Bromotyrosine and 3, 5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry 1999;38:3538-3548.
13. Wu W, Samoszuk MK, Comhair SA, et al. Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest. 2000;105:1455-1463.
14. Henderson JP, Byun J, Williams MV, Mueller DM, McCormick ML, Heinecke JW. Production of brominating intermediates by myeloperoxidase. A transhalogenation pathway for generating mutagenic nucleobases during inflammation. J Biol Chem. 2001;276:7867-7875.
15. Whiteman M, Jenner A, Halliwell B. Hypochlorous acid-induced base modifications in isolated calf thymus DNA. Chem Res Toxicol. 1997;10:1240-1246.
16. Badouard C, Masuda M, Nishino H, Cadet J, Favier A, Ravanat JL. Detection of chlorinated DNA and RNA nucleosides by HPLC coupled to tandem mass spectrometry as potential biomarkers of inflammation. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;827:26-31.
17. Riggs AD, Jones PA. 5-methylcytosine, gene regulation, and cancer. Adv Cancer Res. 1983;40:1-30.
18. Shi K, Pan B, Tippin D, Sundaralingam M. Structures of d(Gm5)CGm5CGCGC) and d(GCGCGm5CGm5C): effects of methylation on alternating DNA octamers. Acta Crystallogr D Biol Crystallogr. 2004;60:61-65.
19. Szyf M, Targeting DNA methylation in cancer. Ageing Res Rev. 2003;2:299-328.
20. Valinluck V, Liu P, Kang JI Jr., Burdzy A, Sowers LC. 5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2). Nucleic Acids Res. 2005;33:3057-3064.
21. Valinluck V, Sowers LC. Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers. Cancer Res. 2007;67:5583-5586.
22. Valinluck V, Sowers LC. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 2007;67:946-950.
23. Kang JI Jr., Burdzy A, Liu P, Sowers LC. Synthesis and characterization of oligonucleotides containing 5-chlorocytosine. Chem Res Toxicol. 2004;17:1236-1244.
24. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;129:S1-32.
25. Citardi MJ, Song W, Batra PS, Lanza DC, Hazen SL. Characterization of oxidation pathways in chronic rhinosinusitis and sinonasal polyposis. Am. J. Rhinology. 2006;20:353-359.
26. Henderson JP, Byun J, Takeshita J, Heinecke JW. Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue. J Biol Chem. 2003;278:23522-23528.
27. Henderson JP, Byun J, Mueller DM, Heinecke JW. The eosinophil peroxidase-hydrogen peroxide-bromide system of human eosinophils generates 5-bromouracil, a mutagenic thymine analogue. Biochemistry. 2001;40:2052-2059.
28. Paz MF, Fraga MF, Avila S. et al. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res 2003;63:1114-1121.
29. Feinberg AP. Alterations in DNA methylation in colorectal polyps and cancer. Prog Clin Biol Res. 1988;279:309-317.
30. Lao VV, Herring JL, Kim CH, Darwanto A, Soto U, Sowers LC. Incorporation of 5- chlorocytosine into mammalian DNA results in heritable gene silencing and altered cytosine methylation patterns. Carcinogenesis. 2009;30:886-893.